What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
<h4>Background</h4>In addition to the clear cardiovascular benefit, there has been renewed interest in the potential of statins in the prevention of cognitive impairment and dementia in older adults. However, whether ongoing statin use can delay cognitive decline or dementia progression...
Main Authors: | Claire Murphy, Adam H Dyer, Brian Lawlor, Sean P Kennelly, NILVAD study group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0285529 |
Similar Items
-
Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD
by: Adam H. Dyer, et al.
Published: (2020-03-01) -
Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
by: Miguel Germán Borda, et al.
Published: (2019-04-01) -
Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study
by: Bojana Petek, et al.
Published: (2023-12-01) -
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
by: Brian Lawlor, et al.
Published: (2018-09-01) -
Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
by: Jonas Hannestad, et al.
Published: (2020-01-01)